These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 16772170)

  • 1. Wlds protection distinguishes axon degeneration following injury from naturally occurring developmental pruning.
    Hoopfer ED; McLaughlin T; Watts RJ; Schuldiner O; O'Leary DD; Luo L
    Neuron; 2006 Jun; 50(6):883-95. PubMed ID: 16772170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
    Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
    Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons.
    MacDonald JM; Beach MG; Porpiglia E; Sheehan AE; Watts RJ; Freeman MR
    Neuron; 2006 Jun; 50(6):869-81. PubMed ID: 16772169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal involvement in the Wlds neuroprotective effect: analysis of pure motoneurons in a mouse model protected from motor neuron disease at a pre-symptomatic age.
    Simonin Y; Perrin FE; Kato AC
    J Neurochem; 2007 Apr; 101(2):530-42. PubMed ID: 17402973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration.
    Meyer zu Horste G; Miesbach TA; Muller JI; Fledrich R; Stassart RM; Kieseier BC; Coleman MP; Sereda MW
    Neurobiol Dis; 2011 Apr; 42(1):1-8. PubMed ID: 21168501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local axonal protection by WldS as revealed by conditional regulation of protein stability.
    Wang JT; Medress ZA; Vargas ME; Barres BA
    Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10093-100. PubMed ID: 26209654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demyelination can proceed independently of axonal degradation during Wallerian degeneration in wlds mice.
    Takada H; Yuasa S; Araki T
    Eur J Neurosci; 2011 Aug; 34(4):531-7. PubMed ID: 21749497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.
    Kitay BM; McCormack R; Wang Y; Tsoulfas P; Zhai RG
    Hum Mol Genet; 2013 Apr; 22(8):1601-14. PubMed ID: 23314018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The slow Wallerian degeneration gene in vivo protects motor axons but not their cell bodies after avulsion and neonatal axotomy.
    Adalbert R; Nógrádi A; Szabó A; Coleman MP
    Eur J Neurosci; 2006 Oct; 24(8):2163-8. PubMed ID: 17074042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axon degeneration mechanisms: commonality amid diversity.
    Coleman M
    Nat Rev Neurosci; 2005 Nov; 6(11):889-98. PubMed ID: 16224497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rat model of slow Wallerian degeneration (WldS) with improved preservation of neuromuscular synapses.
    Adalbert R; Gillingwater TH; Haley JE; Bridge K; Beirowski B; Berek L; Wagner D; Grumme D; Thomson D; Celik A; Addicks K; Ribchester RR; Coleman MP
    Eur J Neurosci; 2005 Jan; 21(1):271-7. PubMed ID: 15654865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WldS can delay Wallerian degeneration in mice when interaction with valosin-containing protein is weakened.
    Beirowski B; Morreale G; Conforti L; Mazzola F; Di Stefano M; Wilbrey A; Babetto E; Janeckova L; Magni G; Coleman MP
    Neuroscience; 2010 Mar; 166(1):201-11. PubMed ID: 20018231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves.
    Beirowski B; Adalbert R; Wagner D; Grumme DS; Addicks K; Ribchester RR; Coleman MP
    BMC Neurosci; 2005 Feb; 6():6. PubMed ID: 15686598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative and qualitative analysis of Wallerian degeneration using restricted axonal labelling in YFP-H mice.
    Beirowski B; Berek L; Adalbert R; Wagner D; Grumme DS; Addicks K; Ribchester RR; Coleman MP
    J Neurosci Methods; 2004 Mar; 134(1):23-35. PubMed ID: 15102500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity.
    Yan T; Feng Y; Zheng J; Ge X; Zhang Y; Wu D; Zhao J; Zhai Q
    Neurochem Int; 2010 Jan; 56(1):101-6. PubMed ID: 19778564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degeneration of neuronal cell bodies following axonal injury in Wld(S) mice.
    Wang AL; Yuan M; Neufeld AH
    J Neurosci Res; 2006 Dec; 84(8):1799-807. PubMed ID: 17022038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of vincristine-induced neuropathy by WldS expression and the independence of the activity of Nmnat1.
    Watanabe M; Tsukiyama T; Hatakeyama S
    Neurosci Lett; 2007 Jan; 411(3):228-32. PubMed ID: 17113230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WldS mice are resistant to paclitaxel (taxol) neuropathy.
    Wang MS; Davis AA; Culver DG; Glass JD
    Ann Neurol; 2002 Oct; 52(4):442-7. PubMed ID: 12325073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration.
    Conforti L; Janeckova L; Wagner D; Mazzola F; Cialabrini L; Di Stefano M; Orsomando G; Magni G; Bendotti C; Smyth N; Coleman M
    FEBS J; 2011 Aug; 278(15):2666-79. PubMed ID: 21615689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axon degeneration: Mechanisms and implications of a distinct program from cell death.
    Yan T; Feng Y; Zhai Q
    Neurochem Int; 2010 Mar; 56(4):529-34. PubMed ID: 20117162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.